FIBRINOGEN HUMAN Pharmacologic Class Indexing
- Class set ID
- a581ffb5-c37c-4075-9451-4b9e42abd353
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use FESILTY safely and effectively. See full prescribing information for FESILTY. FESILTY (fibrinogen, human - chmt), lyophilized powder for reconstitution, for intravenous use Initial U.S. Approval: 2025 | Grifols USA LLC | Biotest AG | Grifols Therapeutics LLC | Laboratorios Grifols, S.A. | Instituto Grifols, S.A. | Prothya Biosolutions Belgium | TechPharm GmbH | GBA Pharma GmbH | 20251230 | 2 |
| These highlights do not include all the information needed to use RIASTAP ® safely and effectively. See full prescribing information for RIASTAP. RIASTAP, Fibrinogen Concentrate (Human) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 2009 | CSL Behring GmbH | 20251229 | 19 |
| These highlights do not include all the information needed to use TACHOSIL safely and effectively. See full prescribing information for TACHOSIL. TACHOSIL ® Fibrin Sealant Patch Absorbable Patch for Topical Use Initial U.S. Approval: 2010 | Corza Medical GmbH | 20251008 | 7 |
| These highlights do not include all the information needed to use ARTISS safely and effectively. See full prescribing information for ARTISS. ARTISS [Fibrin Sealant (Human)] Frozen Solution for topical application Initial U.S. Approval: 2008 | Baxter Healthcare Corporation | 20250930 | 12 |
| These highlights do not include all the information needed to use TISSEEL safely and effectively. See full prescribing information for TISSEEL. TISSEEL [Fibrin Sealant] Frozen solution and lyophilized powder for solution for topical use only Initial U.S. Approval: 1998 | Baxter Healthcare Corporation | 20250930 | 9 |
| These highlights do not include all the information needed to use VISTASEAL™ safely and effectively. See full prescribing information for VISTASEAL. VISTASEAL™ [Fibrin Sealant (Human)] Frozen solutions of fibrinogen and thrombin For Topical Use Only Initial U.S. Approval: 2017 | GRIFOLS USA, LLC | Instituto Grifols SA | 20250813 | 14 |
| These highlights do not include all the information needed to use FIBRYGA safely and effectively. See full prescribing information for FIBRYGA. FIBRYGA® [fibrinogen (human)] Lyophilized Powder for Reconstitution, For Intravenous Use Initial U.S. Approval: 2017 | Octapharma USA Inc | 20250805 | 4 |
| These highlights do not include all the information needed to use EVARREST ® safely and effectively. See full prescribing information for EVARREST ® . EVARREST ® Fibrin Sealant Patch Absorbable Patch for Topical Use Initial U.S. Approval: 2012 | Ethicon, Inc. | Omrix Biopharmaceuticals Ltd. | 20250210 | 14 |
| These highlights do not include all the information needed to use VISTASEAL™ safely and effectively. See full prescribing information for VISTASEAL. VISTASEAL™ [Fibrin Sealant (Human)] Frozen solutions of fibrinogen and thrombin For Topical Use Only Initial U.S. Approval: 2017 | GRIFOLS USA, LLC | Instituto Grifols SA | 20241216 | 2 |
| These highlights do not include all the information needed to use FIBRYGA safely and effectively. See full prescribing information for FIBRYGA. FIBRYGA® [fibrinogen (human)] Lyophilized Powder for Reconstitution, For Intravenous Use Initial U.S. Approval: 2017 | Octapharma USA Inc | 20240731 | 13 |